AttractivenessNCT05739721
ZOOM First Impressions
A study testing Attractiveness, Self-Esteem and Trustworthiness in people with Attractiveness and Self Esteem, run by DeNova Research at 1 site in United States.
Trial summary
Participants (random) will have a conversation with each other over zoom initially with their cameras off and then rate each other on attractiveness, first impressions, and self-esteem. Then both participants will turn their cameras back on and have another conversion and then again rate each other. Read more about this study
- Who is it for?
- Ages 21 to 39 yearsHealthy volunteers can take part
- Conditions the study is for
- Attractiveness, Self Esteem, First Impressions
- What is being tested?
- Attractiveness, Self-Esteem and Trustworthiness
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 0 participants
- Where
- 1 siteUnited States
- Study dates
- 1 Nov 2021to 1 Nov 2022
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 21 to 39 years
- All sexes
- Healthy volunteers accepted
- Adult
Who may be able to join
- Males and females of ages 21-39.
- Subjects that understand the purpose and aspects of the study, freely sign the consent and complete the required treatment and follow up visit.
- Subjects must all be able to speak English fluently.
- Subjects must have access to video camera technology.
- Fully Vaccinated against covid-19
Who cannot join
- Participants younger than 21 or older than 40 will not be included.
- Subjects who are pregnant or nursing.
- Imprisoned populations.
- Subjects who are unable to travel to the clinic.
- Subjects that do not understand the purpose and aspects of the study, do not sign the consent and do not complete the required virtual session and follow-up visit will also be excluded.
- Any subject that is not fully vaccinated against covid-19
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Effects of Video Conferencing on First Impressions and Attractiveness
Participants (random) will have a conversation with each other over zoom initially with their cameras off and then rate each other on attractiveness, first impressions, and self-esteem. Then both participants will turn their cameras back on and have another conversion and then again rate each other. The ratings are confidential and will not be shared with the other person.
Two months later the participants will come to the study clinic office and have an in-person conversation with someone new and rate each other.
- Conditions
- Attractiveness, Self Esteem, First Impressions
- Being tested
- Attractiveness, Self-Esteem, Trustworthiness
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
AttractivenessBehavioural
Visual attractiveness scale 0-7
Self-EsteemBehavioural
Self Esteem scale
TrustworthinessBehavioural
Trustworthiness scale 0-7
| Study group | Role | What they receive |
|---|---|---|
| Zoom meeting (camera off) | Experimental | participants will be randomly assigned to a Zoom (San Jose, CA, USA) video conference meeting with another participant of the opposite gender Receives: Behavioral: Attractiveness; Behavioral: Self-Esteem; Behavioral: Trustworthiness |
| In person meeting (blindfolded) | Experimental | Once all subjects have been selected and enrolled in the study, participants will be randomly assigned for an in-person meeting. Receives: Behavioral: Attractiveness; Behavioral: Self-Esteem; Behavioral: Trustworthiness |
| Zoom meeting (camera on) | Experimental | participants will be randomly assigned to a Zoom (San Jose, CA, USA) video conference meeting with another participant of the opposite gender Receives: Behavioral: Attractiveness; Behavioral: Self-Esteem; Behavioral: Trustworthiness |
| In person meeting (no blindfold) | Experimental | Once all subjects have been selected and enrolled in the study, participants will be randomly assigned for an in-person meeting. Receives: Behavioral: Attractiveness; Behavioral: Self-Esteem; Behavioral: Trustworthiness |
What is being measured
The primary outcome is the main question the study is designed to answer.
First Impressions
The defined categories of first impressions include: Social skills, academic performance, dating success, occupational success, attractiveness, financial success, relationship success, and athletic success. The scale ranges from a score of 1 (less desirable) to 10 (most desirable). Scores closer to 10 signify a more positive outcome.
Measured: 8 weeks
Trustworthiness scale
Scale 0 (disagree) - 7 (agree). Scores closer to 7 signify a more positive outcome.
Measured: 8 weeks
Overall Attractiveness
Scale 0 (disagree) - 7 (agree). Scores closer to 7 signify a more positive outcome.
Measured: 8 weeks
Secondary outcomes (1)
Self-Esteem
The Rosenberg Self-Esteem Scale is a 10-item self-report measure of global self-esteem. It consists of 10 statements related to overall feelings of self-worth or self-acceptance. The items are answered on a four-point scale ranging from strongly agree, agree, disagree, and strongly disagree.
Measured: 8 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted22 Feb 2023
- Study start1 Nov 2021
- Primary completion1 Oct 2022
- Study completion1 Nov 2022
Why it stopped: No funding
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for AttractivenessStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- None (open label)
- Enrolment
- 0 participants (actual)
Sponsor and investigators
- Lead sponsor
- DeNova Research
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Steven H. Dayan, DeNova Research
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05739721
- Sponsor's protocol ID
- ZOOM-SD-2021
- Status last verified
- Feb 2023
- First submitted
- 19 Apr 2022
- Last updated
- 22 Feb 2023
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 22 Feb 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effects of Video Conferencing on First Impressions and Attractiveness
- ClinicalTrials.gov ID
- NCT05739721
- Acronym / sponsor ID
- ZOOM-SD-2021
- Conditions
- Attractiveness, Self Esteem, First Impressions
- Study type
- Interventional
- Recruitment status
- WithdrawnReason stopped: No funding
- Enrolment
- 0 participants (actual)
- Lead sponsor
- DeNova ResearchUniversity, hospital or other
- Study start
- 1 Nov 2021 (actual)
- Primary completion
- 1 Oct 2022 (actual)
- Study completion
- 1 Nov 2022 (actual)
- First posted
- 22 Feb 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Participants (random) will have a conversation with each other over zoom initially with their cameras off and then rate each other on attractiveness, first impressions, and self-esteem. Then both participants will turn their cameras back on and have another conversion and then again rate each other. The ratings are confidential and will not be shared with the other person.
Two months later the participants will come to the study clinic office and have an in-person conversation with someone new and rate each other.
Study design
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- None (open label)
- Number of arms
- 4
| Arm | Type | Receives |
|---|---|---|
| Zoom meeting (camera off) | Experimental | Behavioral: Attractiveness, Behavioral: Self-Esteem, Behavioral: Trustworthinessparticipants will be randomly assigned to a Zoom (San Jose, CA, USA) video conference meeting with another participant of the opposite gender |
| In person meeting (blindfolded) | Experimental | Behavioral: Attractiveness, Behavioral: Self-Esteem, Behavioral: TrustworthinessOnce all subjects have been selected and enrolled in the study, participants will be randomly assigned for an in-person meeting. |
| Zoom meeting (camera on) | Experimental | Behavioral: Attractiveness, Behavioral: Self-Esteem, Behavioral: Trustworthinessparticipants will be randomly assigned to a Zoom (San Jose, CA, USA) video conference meeting with another participant of the opposite gender |
| In person meeting (no blindfold) | Experimental | Behavioral: Attractiveness, Behavioral: Self-Esteem, Behavioral: TrustworthinessOnce all subjects have been selected and enrolled in the study, participants will be randomly assigned for an in-person meeting. |
Who may qualify
- Ages
- 21 to 39 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (5 listed)
- Males and females of ages 21-39.
- Subjects that understand the purpose and aspects of the study, freely sign the consent and complete the required treatment and follow up visit.
- Subjects must all be able to speak English fluently.
- Subjects must have access to video camera technology.
- Fully Vaccinated against covid-19
Key exclusion criteria (6 listed)
- Participants younger than 21 or older than 40 will not be included.
- Subjects who are pregnant or nursing.
- Imprisoned populations.
- Subjects who are unable to travel to the clinic.
- Subjects that do not understand the purpose and aspects of the study, do not sign the consent and do not complete the required virtual session and follow-up visit will also be excluded.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| AttractivenessVisual attractiveness scale 0-7 | Behavioural | In person meeting (blindfolded), In person meeting (no blindfold), Zoom meeting (camera off), Zoom meeting (camera on) |
| Self-EsteemSelf Esteem scale | Behavioural | In person meeting (blindfolded), In person meeting (no blindfold), Zoom meeting (camera off), Zoom meeting (camera on) |
| TrustworthinessTrustworthiness scale 0-7 | Behavioural | In person meeting (blindfolded), In person meeting (no blindfold), Zoom meeting (camera off), Zoom meeting (camera on) |
Primary outcome
First Impressions
Time frame: 8 weeks
The defined categories of first impressions include: Social skills, academic performance, dating success, occupational success, attractiveness, financial success, relationship success, and athletic success. The scale ranges from a score of 1 (less desirable) to 10 (most desirable). Scores closer to 10 signify a more positive outcome.
Trustworthiness scale
Time frame: 8 weeks
Scale 0 (disagree) - 7 (agree). Scores closer to 7 signify a more positive outcome.
Overall Attractiveness
Time frame: 8 weeks
Scale 0 (disagree) - 7 (agree). Scores closer to 7 signify a more positive outcome.
1 secondary outcome
Self-Esteem
Time frame: 8 weeks
Results and safety
The study was withdrawn before enrolling participants, so there are no results.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 22 Feb 2023.
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Attractiveness, Self-Esteem and Trustworthiness in people with Attractiveness and Self Esteem, run by DeNova Research at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: withdrawn, as of the sponsor's last update on 22 Feb 2023. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study was withdrawn before enrolling participants, so there are no results.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
First Impressions (time frame: 8 weeks). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Feb 2023; AzTrials last refreshed its copy on 27 Oct 2026.